AIP
PSTX

Ameritas Investment Partners’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Ameritas Investment Partners’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,182
Closed -$68.9K – 3177
2024
Q4 		$68.9K Buy
7,182
+1,570
+28% +$8.19K ﹤0.01% 1993
2024
Q3 		$16.1K Hold
5,612
– – ﹤0.01% 2744
2024
Q2 		$16.4K Hold
5,612
– – ﹤0.01% 2702
2024
Q1 		$17.9K Hold
5,612
– – ﹤0.01% 2599
2023
Q4 		$18.9K Hold
5,612
– – ﹤0.01% 2601
2023
Q3 		$13.4K Hold
5,612
– – ﹤0.01% 2711
2023
Q2 		$9.88K Buy
+5,612
New +$14.3K ﹤0.01% 2916
2022
Q2 		– Sell
-2,693
Closed -$12K – 3275
2022
Q1 		$12K Hold
2,693
– – ﹤0.01% 2748
2021
Q4 		$18K Hold
2,693
– – ﹤0.01% 2698
2021
Q3 		$20K Hold
2,693
– – ﹤0.01% 2714
2021
Q2 		$27K Hold
2,693
– – ﹤0.01% 2577
2021
Q1 		$26K Buy
2,693
+1,549
+135% +$15.2K ﹤0.01% 2457
2020
Q4 		$13K Hold
1,144
– – ﹤0.01% 2692
2020
Q3 		$10K Buy
+1,144
New +$13K ﹤0.01% 2732

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameritas Investment Partners's PSTX Position: Q1 2025 in Review

Ameritas Investment Partners sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 7,182 shares — an estimated $68.9K sold.

Ameritas Investment Partners first reported a position in PSTX in Q3 2020 and held it in 14 quarters. The position peaked at $68.9K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Ameritas Investment Partners reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 7,182 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $68.9K.
  • Ameritas Investment Partners first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Ameritas Investment Partners's Poseida Therapeutics, Inc. Common Stock position peaked at $68.9K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Ameritas Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.